Skip to content

The psychotherapeutic component of psychedelic medicine

Laurie Higbed, Ben Sessa

Psychedelics as Psychiatric Medications March 1, 2023 DOI: 10.1093/med/9780192863607.003.0002 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Theoretical or philosophical paper Peer reviewed
Intervention Psychedelic-assisted psychotherapy
Key points Proposes that psychedelic-assisted psychotherapy, through its phases of preparation, experiential sessions, and integration, offers a holistic biopsychosocial intervention that embraces an individualized formulation-driven understanding of mental distress.

Abstract

Abstract Psychedelic compounds offer a unique type of mental health treatment. This chapter considers how psychedelics can be explored as an alternative to the typical maintenance medication for the treatment of symptoms, through using psychedelic medicines in a controlled clinical setting as an adjunct to psychotherapy. In combination with psychotherapy, the psychedelic experience provides the opportunity to access and explore the root cause of individuals’ difficulties. The ability of psychedelic-assisted psychotherapy to embrace an individualized formulation-driven rather than a reductionist diagnostic-focused understanding of mental distress is discussed, with this therapeutic approach offering a holistic biopsychosocial intervention. Whilst therapeutic modalities of psychedelic-assisted psychotherapy may vary, this chapter details the key therapeutic phases of preparation, psychedelic drug–assisted experiential sessions, and post-drug integration to explore how psychedelics benefit therapy for a range of mental health problems.

Citations in the library

Explore topics